ATHN 7: Hemophilia Natural History Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Recht, MD, PhD
The Hemophilia Center at Oregon Health & Science University
Principal Investigator - Tyler Buckner, MD, MSc
Hemophilia and Thrombosis Center/ University of Colorado Anschutz Medical Campus
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Hemophilia and Thrombosis Center at Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Orthopaedic Institute for Children Htc
Los Angeles, California, United States
- Orthopedic Institute for Children Hemophilia Program
Los Angeles, California, United States
- Rady Children'S Hospital San Diego
San Diego, California, United States
- Hemophilia and Thrombosis Center/ University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
- University of Florida Hemophilia Treatment Center
Gainesville, Florida, United States
- Comprehensive Bleeding Disorders Center at Emory University and Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Indiana Hemophilia and Thrombosis Center (ihtc)
Indianapolis, Indiana, United States
- Louisiana Center for Bleeding and Clotting Disorders
New Orleans, Louisiana, United States
- Louisiana Center for Bleeding and Clotting Disorders, Tulane University
New Orleans, Louisiana, United States
- Maine Hemophilia and Thrombosis Center
Scarborough, Maine, United States
- Massachusetts General Hospital Comprehensive Hemophilia and Thrombosis Treatment Center
Boston, Massachusetts, United States
- Michigan State University Center for Bleeding and Clotting Disorders
East Lansing, Michigan, United States
- Children'S Mercy Hospital - Kansas City
Kansas City, Missouri, United States
- the John Bouhasin Center for Children With Bleeding Disorders
St Louis, Missouri, United States
- Hemostasis and Thrombosis Center of Nevada
Las Vegas, Nevada, United States
- Hemostasis and Thrombosis Center of Nevada
Reno, Nevada, United States
- Newark Beth Israel Medical Center
Newark, New Jersey, United States
- Weill Cornell Medicine
New York, New York, United States
- Wake Forest University Health Science
Winston-Salem, North Carolina, United States
- Northwest Ohio Hemophilia Treatment Center at the Toledo Hospital
Toledo, Ohio, United States
- the Hemophilia Center at Oregon Health & Science University
Portland, Oregon, United States
- Children'S Hospital of Philadelphia (chop)
Philadelphia, Pennsylvania, United States
- Penn Comprehensive Hemophilia and Thrombophilia Program/hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- St Jude Children'S Research Hospital
Memphis, Tennessee, United States
- the Center for Cancer and Blood Disorders, Children'S Medical Center of Dallas
Dallas, Texas, United States
- Gulf States Hemophilia and Thrombosis Center
Houston, Texas, United States
- Comprehensive Center for Bleeding Disorders
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Oct 2018
- Primary completion
- 31 May 2023
- Completion
- 31 Mar 2024
- Last update posted
- 12 Feb 2025
- Registered enrollment
- 395
- Registry id
- NCT03619863
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.